SAJJAD MOHAMMAD: Open Payments
NPI 1033290242 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,437 in 133 payments from 6 companies in 2025. Trend: 2023 $2,294 · 2024 $3,080 · 2025 $3,437
Food & beverage: $2,844Travel & lodging: $594
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 99 | $2,660 |
| Gilead Sciences, Inc. | 26 | $534 |
| Novo Nordisk Inc | 1 | $102 |
| Paratek Pharmaceuticals, Inc. | 4 | $77 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Indivior Inc. | 1 | $22 |
Products named: DOVATO, APRETUDE, CABENUVA, RUKOBIA, Ozempic, NUZYRA, VERQUVO, Biktarvy.
Industry payments across NY — which companies pay providers there.
